Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Down 54.3% in February

Ocean Biomedical, Inc. (NASDAQ:OCEAW) saw a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 6,900 shares, a decline of 54.3% from the February 13th total of 15,100 shares. Based on an average daily trading volume, of 59,700 shares, the days-to-cover ratio is currently 0.1 days.

Ocean Biomedical Stock Down 6.5 %

Ocean Biomedical stock traded down $0.00 during trading on Friday, reaching $0.02. 5,500 shares of the company’s stock were exchanged, compared to its average volume of 41,446. Ocean Biomedical has a 52-week low of $0.02 and a 52-week high of $0.42. The company’s 50-day moving average is $0.03 and its two-hundred day moving average is $0.04.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.